Brief: United Laboratories International Says Meropenem For Injection Submitted Passed Evaluation
06/09/2023 11:54
Sept 6 (Reuters) - United Laboratories International
Holdings Ltd 3933.HK :
* MEROPENEM FOR INJECTION SUBMITTED BY UNIT PASSED
CONSISTENCY
EVALUATION OF QUALITY AND EFFICACY FOR GENERIC DRUGS
Source text for Eikon: ID:nHKS7tXKkP
Further company coverage: 3933.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on United Laboratories International Holdings
See all newsBrief: United Laboratories International Receives Milestone Payment From Novo
Brief: United Laboratories International Says NMPA Accepts Insulin Degludec And Liraglutide Injection Marketing Registration Application
Brief: United Laboratories International Posts HY Profit Attributable RMB 347.6 Million
China's United Laboratories half-year profit drops 82%
Brief: United Laboratories International Expects HY Net Profit RMB 340 Million